November 2020: Oncology

Industry News Round-up

In this weeks oncology round-up, we’ve gathered information on the role of long non-coding RNAs in the development of pancreatic cancer, insight into a gene signature in localized prostate cancer, and new applications of cells in cancer therapies.

November 4, 2020 / Duke

Innovative research has shed light on the mysterious role of long non-coding RNAs in the development of pancreatic cancer and suggests potential new targets for precision cancer therapies.

November 9, 2020 / Columbia University  

Researchers have identified a gene signature in localized prostate cancer that predicts the cancer’s odds of spreading and its response to a common treatment for advanced disease.

November 12, 2020 / University of California

When it comes to complex life — that of the multicellular variety — cell death can be just as important as survival. It allows organisms to clean house and prevent the proliferation of damaged cells that could compromise tissue function.

ONCOLOGY

Download PharPoint’s oncology experience overview

[contact-form-7 id=”9108″]